Voters Expect to Be Informed If They Are Prescribed A Drug Not Approved By the FDA WASHINGTON – As Congress considers legislation to address the oversight of compounding pharmacies, a new, independent survey released today highlights the large gap between voters’ expectations that the medications they receive are FDA-approved and loopholes in federal law that [Read More]
News
C3 Gene Variant Linked To Macular Degeneration
Researchers report that a change in the C3 gene, which plays a role in inflammation and in the body’s immune response, also contributes to macular degeneration. After sequencing DNA from 10 regions of the genome that had been previously linked to AMD in previous genetic studies, the researchers turned up two gene variants: one in the [Read More]
High Dose Stem Cell Transplant Performed
Stem Cells (STEM) has announced the first patient to receive a high dose of one million purified human neural stem cells (HuCNS-SC®) in their Phase 1/2 clinical trial. This followed an independent review by the Data Safety Monitoring Committee, which found no safety issues with proceeding to the high dose. The 16-patient trial is designed to evaluate the [Read More]
Prevent Blindness America Launches New Online Resource, "Living Well with Low Vision"
To directly address the needs of those with low vision and their caregivers, Prevent Blindness America has launched a new online resource: “Living Well with Low Vision”. The goal of the new website is to make it as easy as possible for people to educate themselves about loss of vision, to meet the daily challenges [Read More]
New Stem Cell Eye Treatment Study Beginning
(Updated March 12, 2017) MD Stem Cells has announced a new and extensive stem cell study to determine effectiveness of stem cells in ophthalmic disease. The company has been named collaborator for the new Stem Cell Ophthalmology Treatment Study (SCOTS), being conducted in Florida. Conditions eligible for the new study include retinal diseases such as age-related [Read More]